{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/MuriloKrominski/DNA-X-Doencas-e-Predisposicoes-Geneticas/blob/main/Analisador_de_DNA_X_Doen%C3%A7as_e_Predisposi%C3%A7%C3%B5es_Gen%C3%A9ticas.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "6oh2rDm0Kw8s"
      },
      "source": [
        "contato: murilo.krominski@fgv.edu.br - Por Murilo Krominski\n",
        "\n",
        "Considere apoiar este trabalho para permitir futuras atualizações.\n",
        "O Banco de Dados de Doenças e Predisposições Genéticas precisa passar por atualizações conforme novas descobertas genéticas são realizadas.\n",
        "\n",
        "`Murilo Krominski PIX:contato@krominski.com.br`\n",
        "\n",
        "\n",
        "---\n",
        "\n",
        "\n",
        "> **Veja o que seu DNA diz sobre a sua saúde!**\n",
        "\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "lYHuMqii3Msl"
      },
      "source": [
        "# Analisador de DNA X Doenças e Predisposições Genéticas Gratuito e OpenSource\n",
        "\n",
        "Idealizado e criado por Murilo Krominski, este é o primeiro Analisador de DNA X Doenças e Predisposições Genéticas gratuito, de código aberto e colaborativo (OpenSource no GitHub).\n",
        "\n",
        "Dedico esse trabalho para quem tem interesse em Genética/Ciência de Dados e aos que querem saber sobre suas predisposições genéticas de saúde, mas que não teriam acesso a um plano \"premium\" de sequenciamento genético, devido ao custo ainda muito elevado, e teriam portanto, apenas acesso a um plano básico.\n",
        "\n",
        "Qualquer pessoa que possua os dados Brutos do seu DNA (Raw Data), poderá com este trabalho saber mais sobre si, tendo acesso a informações extremamente valiosas (que acredito que todos deveriam ter desde a infância).\n",
        "Para se obter esse arquivo, deve ser feito um exame de DNA e entregar para um laboratório para análise.\n",
        "Bem, com um plano básico voltado à ancestralidade, já é possível ter acesso aos dados brutos do DNA, então, por um valor extremamente mais acessível do que custa um teste completo, é possível fazer um upgrade no que você conhece sobre você.\n",
        "\n",
        "Qualquer um poderá conhecer as suas predisposições genéticas, com um simples teste de cotonete na bochecha!\n",
        "\n",
        "**É importante saber que há outros fatores, além dos genéticos, que influenciam no seu corpo, e que uma predisposição não é um sentença.**\n",
        "\n",
        "**Com os resultados abaixo, você poderá se planejar melhor para o futuro.**"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# DOENÇAS"
      ],
      "metadata": {
        "id": "qEE7Fv4zB7-X"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "Por hora analisa apenas 18 variantes genéticas associadas ao desenvolvimentos de doenças, mas irá aumentar em futuras atualizações que eu realizar, e trata de descobrir problemas como:\n",
        "\n",
        "*   Doença de Wilson\n",
        "*   Deficiência de Alfa-1 Antitripsina (variante PI*Z)\n",
        "*   Deficiência de Alfa-1 Antitripsina (variante PI*S)\n",
        "*   Deficiência de fator XII\n",
        "*   Trombofilia (Fator II - Protrombina)\n",
        "*   Trombofilia (Fator V de Leiden)\n",
        "*   Hemocromatose tipo 1 (variante H63D)\n",
        "*   Hemocromatose tipo 1 (variante C282Y)\n",
        "*   Hemocromatose tipo 1 (variante S65C)\n",
        "*   Infarto do miocárdio\n",
        "*   Doenças mieloproliferativas\n",
        "*   Amiloidose hereditária (variante V122I)\n",
        "*   Amiloidose hereditária (variante V50M)\n",
        "*   Amiloidose hereditária (variante T80A)\n",
        "*   Polipose associada ao gene MUTYH (variante G396D)\n",
        "*   Doença de Parkinson e Doença de Gaucher (gene GBA)\n",
        "*   Doença de Parkinson (gene LRRK2)\n",
        "*   Câncer"
      ],
      "metadata": {
        "id": "L8Y1kO9jCLvz"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# FÁRMACOS"
      ],
      "metadata": {
        "id": "JD6ty7FVB8Tt"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "Informações relacionadas a como o seu corpo reage a determinados medicamentos com base no seu DNA. Os resultados podem te auxiliar na escolha de tratamentos mais eficazes ao seu organismo e a reduzir os seus efeitos colaterais. Tratamentos com medicamentos devem ser realizados somente sob a supervisão de um profissional capacitado.\n",
        "\n",
        "*   Ácido acetilsalicílico (Aspirina®)\n",
        "*   Ácido acetilsalicílico (Aspirina Prevent®)\n",
        "*   Antiinflamatórios\n",
        "*   Bisfosfonatos\n",
        "*   Estatinas\n",
        "*   Atorvastatina (Lípitor®)\n",
        "*   Sinvastatina (Zocor®)\n",
        "*   Hidroclorotiazida (Clorana®)\n",
        "*   Metformina (Glifage®)\n",
        "*   Nicotina\n",
        "*   Opioides\n",
        "*   Salbutamol (Aerolin®) e Salmeterol (Serevent®)\n",
        "*   Sildenafil (Viagra®)\n",
        "*   Sulfonilureias"
      ],
      "metadata": {
        "id": "IFU3i9KQDAVc"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# NUTRIÇÃO"
      ],
      "metadata": {
        "id": "JDxGGfkgJT6k"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "Veja como o seu corpo absorve e interage com certos nutrientes e vitaminas e, também, a eficácia de determinadas dietas. Os resultados podem te ajudar a desenvolver hábitos alimentares com base nas necessidades do seu organismo. Além das características genéticas, há outros fatores que podem interferir no metabolismo de uma pessoa, como a alimentação, fatores psicológicos e o uso de medicamentos.\n",
        "\n",
        "*   Vitamina B6\n",
        "*   Vitamina K\n",
        "*   Intolerância à lactose\n",
        "*   Vitamina D\n",
        "*   Sensibilidade à cafeína\n",
        "*   Eficácia da dieta mediterrânea\n",
        "*   Fome emocional\n",
        "*   Eficácia das dietas low fat e high fat\n",
        "*   Eficácia da dieta low carb\n",
        "*   Manutenção de resultados após intervenção para perda de peso\n",
        "*   Ingestão de açúcares\n",
        "*   Armazenamento de gordura\n",
        "*   Folato (Vitamina B9)\n",
        "*   Sobrecarga de ferro\n",
        "*   Sensação de saciedade"
      ],
      "metadata": {
        "id": "lwz5dKfxJak7"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# CORPO"
      ],
      "metadata": {
        "id": "kpnE67XwWuUY"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "Alcance o máximo de desempenho físico e a evite lesões durante os exercícios a partir das informações do seu DNA. Você descobrirá as características do seu corpo em relação a resistência física, ganho de massa e força muscular, dores após exercícios e diversos outros aspectos. Com os resultados, você poderá elaborar treinos personalizados e eficientes. Lembre-se que outros fatores, como a alimentação, histórico de doenças e condições ambientais podem impactar no seu desempenho físico.\n",
        "\n",
        "*   Resistência física\n",
        "*   Performance atlética\n",
        "*   Danos musculares induzidos pela prática de atividade física\n",
        "*   Densidade óssea (força dos ossos)\n",
        "*   Risco de obesidade\n",
        "*   Resposta ao exercício\n",
        "*   Ganho de massa muscular\n",
        "*   Índice de massa corporal (IMC)\n",
        "*   Força muscular\n",
        "*   Tendinopatia de Aquiles\n",
        "*   Capacidade cardiorrespiratória\n",
        "*   Resistência muscular\n",
        "*   Recuperação da frequência cardíaca após exercício físico\n",
        "*   Dor muscular pós-exercício"
      ],
      "metadata": {
        "id": "ZyRgZbGxXHJK"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# PELE"
      ],
      "metadata": {
        "id": "a9S5leepWxtZ"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "Entenda como a sua genética pode influenciar no seu cuidado com a pele. Muitas características da sua pele têm relação com o seu DNA, como o risco de desenvolver acne, o fotoenvelhecimento e o surgimento de manchas e rugas. Conhecer a sua genética te ajudará a entender de quais cuidados sua pele precisa. Fatores ambientais também podem impactar nas características da sua pele.\n",
        "\n",
        "*   Sensibilidade ao sol\n",
        "*   Acne\n",
        "*   Deficiência de Vitamina C\n",
        "*   Vitamina E\n",
        "*   Capacidade antioxidante\n",
        "*   Risco para hiperpigmentação da pele\n",
        "*   Rugas faciais\n",
        "*   Flacidez palpebral"
      ],
      "metadata": {
        "id": "TQudy1H1X0hO"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# IDADE"
      ],
      "metadata": {
        "id": "dMok5yo8Wzr5"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "Informações sobre como o seu DNA impacta no seu envelhecimento. Saber o que a sua genética reserva para o seu futuro te permitirá desenvolver hábitos saudáveis ao longo de todas as etapas da sua vida. O envelhecimento é um processo natural dos seres humanos e passar por ele com corpo e mente sãos é essencial.\n",
        "\n",
        "*   Fotoenvelhecimento\n",
        "*   Calvície\n",
        "*   Diabetes tipo 2\n",
        "*   Longevidade\n",
        "*   Comprimento dos telômeros\n",
        "*   Tremor essencial não relacionado a Parkinson\n",
        "*   Degeneração macular relacionada à idade\n",
        "*   Osteoporose (receptor de vitamina D)"
      ],
      "metadata": {
        "id": "ENO-4sE6YhOs"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# CURIOSIDADE"
      ],
      "metadata": {
        "id": "rn6XuNzUW1pT"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "Ótimas para puxar conversa com seus amigos e comparar os seus resultados. Você vai descobrir o seu nível de impulsividade, se tem uma boa habilidade matemática e predisposição ao alcoolismo. Dá até para saber qual é o seu tipo de cera de ouvido. Interessante, não é?\n",
        "\n",
        "*   Gene guerreiro\n",
        "*   Habilidade matemática\n",
        "*   Visão\n",
        "*   Impulsividade\n",
        "*   Preferência por horários diurnos ou noturnos\n",
        "*   Predisposição ao alcoolismo\n",
        "*   Propensão à dependência de nicotina\n",
        "*   Percepção do gosto amargo\n",
        "*   Cera de ouvido"
      ],
      "metadata": {
        "id": "EX7Ak8PnY-DJ"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Formato Arquivo DNA"
      ],
      "metadata": {
        "id": "YZTYF97CDR6m"
      }
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "uesHY-Ptk7_p"
      },
      "source": [
        "\n",
        "\n",
        "\n",
        "\n",
        "O arquivo de origem deve estar no formato .csv, se chamar \"origem.csv\" e possuir os dados dispostos da seguinte forma: \n",
        "\n",
        "1ª Coluna:\n",
        "RSID: string\n",
        "Se disponível, carrega a variante rsID, que identifica o ramo dentro do banco de dados genético público dbSNP(SNP, sigla em inglês para Polimorfismo de Nucleotídeo Único, é uma variação do DNA em uma única base nucleotídica que nos permite traçar propensões e características..)\n",
        "\n",
        "2ª Coluna:\n",
        "CHROMOSOME: string\n",
        "Indica o número do cromossomo onde se situa a variante genética. Existem 22 pares de cromossomos autossômicos que são indicados com um número e os cromossomos sexuais que são nomeados como X e Y. Há também marcadores no DNA mitocondrial que aparecem listados como “MT”.\n",
        "\n",
        "3ª Coluna:\n",
        "POSITION: string\n",
        "É a posição variante no cromossomo, a posição do marcador genético de acordo com o  conjunto genético humano GRCh37 (http://grch37.ensembl.org/index.html).\n",
        "\n",
        "4ª Coluna:\n",
        "RESULT: string\n",
        "• O par de valores observados (alelo 1 e alelo 2 - representando os lados paterno e materno, não necessariamente nessa ordem), contém resultados de genotipagem para os marcadores genéticos.\n",
        "\n",
        "![image.png](data:image/png;base64,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)"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Carregando DNA que será analisádo:"
      ],
      "metadata": {
        "id": "asTQl0DqujCV"
      }
    },
    {
      "cell_type": "code",
      "execution_count": 1,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 91,
          "resources": {
            "http://localhost:8080/nbextensions/google.colab/files.js": {
              "data": "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",
              "headers": [
                [
                  "content-type",
                  "application/javascript"
                ]
              ],
              "ok": true,
              "status": 200,
              "status_text": ""
            }
          }
        },
        "id": "OVn99nZnLIdr",
        "outputId": "1ff0bdff-445d-4314-b8d8-ac50daad2437"
      },
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "     <input type=\"file\" id=\"files-4963d0ba-2595-4ba0-a390-54ce8eef5901\" name=\"files[]\" multiple disabled\n",
              "        style=\"border:none\" />\n",
              "     <output id=\"result-4963d0ba-2595-4ba0-a390-54ce8eef5901\">\n",
              "      Upload widget is only available when the cell has been executed in the\n",
              "      current browser session. Please rerun this cell to enable.\n",
              "      </output>\n",
              "      <script src=\"/nbextensions/google.colab/files.js\"></script> "
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Saving origem.csv to origem.csv\n",
            "\u001b[H\u001b[2J"
          ]
        }
      ],
      "source": [
        "import pandas as pd\n",
        "\n",
        "###Faça o upload dos dados RAW em do seu DNA como \"origem.csv\", seguindo orientações de formato supracitadas:\n",
        "from google.colab import files\n",
        "files.upload()\n",
        "!clear"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "93RZl6W-3V33"
      },
      "source": [
        "# Carregando Bancos de Dados e o Comparador:"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "doencas_df = pd.read_csv('https://raw.githubusercontent.com/MuriloKrominski/DNA-X-Doencas-e-Predisposicoes-Geneticas/main/doencas.csv', sep=\",\", encoding='utf-8', low_memory=\"False\")\n",
        "doencas_df['RSID+CHROMOSOME+RESULT']= doencas_df['RSID+CHROMOSOME+RESULT'].values.astype(str)\n",
        "\n",
        "origem_df = pd.read_csv('/content/origem.csv', sep=\",\", encoding='utf-8', low_memory=\"False\")\n",
        "\n",
        "origem_df = origem_df.drop(columns=['POSITION'])\n",
        "\n",
        "origem_df['RSID']= origem_df['RSID'].values.astype(str)\n",
        "origem_df['CHROMOSOME']= origem_df['CHROMOSOME'].values.astype(str)\n",
        "origem_df['RESULT']= origem_df['RESULT'].values.astype(str)\n",
        "\n",
        "origem_df['RSID+CHROMOSOME+RESULT'] = origem_df[['RSID','CHROMOSOME','RESULT']].apply(' '.join, axis=1)\n",
        "\n",
        "origem_df = origem_df.drop(['RSID','CHROMOSOME','RESULT'],axis=1)\n",
        "\n",
        "resultado_df = pd.merge(origem_df, doencas_df, \n",
        "                   on=['RSID+CHROMOSOME+RESULT'], \n",
        "                   how='inner')\n",
        "\n",
        "resultado_df = resultado_df.sort_values(['DISEASE'])\n",
        "\n",
        "resultado_df = resultado_df.reset_index(drop=True)"
      ],
      "metadata": {
        "id": "e7JZxobSvlix"
      },
      "execution_count": 2,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "# RESULTADO"
      ],
      "metadata": {
        "id": "elqAzVDwvvwz"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "#Veja o que seu DNA diz sobre a sua saúde! É possível baixar o aresultado em formato CSV).\n",
        "#Considere apoiar este trabalho, e permitir futuras atualizações.\n",
        "#Murilo Krominski PIX:contato@krominski.com.br\n",
        "resultado_df.to_csv(\"resultado.csv\",index=False,encoding='utf-8')\n",
        "resultado_df.to_excel(\"resultado.xlsx\",index=False,encoding='utf-8')\n",
        "\n",
        "resultado_df"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "q6wva7eSbJ-R",
        "outputId": "089dea4e-0c78-4c34-bb5a-274fc20cb53e"
      },
      "execution_count": 3,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "   RSID+CHROMOSOME+RESULT                                            DISEASE\n",
              "0          rs2707466 7 TT  Corpo - Densidade óssea (força dos ossos) - Pr...\n",
              "1            rs12722 9 CT  Corpo - Dor muscular pós-exercício - Maior dor...\n",
              "2         rs1800169 11 GG  Corpo - Força muscular - Predisposição para ma...\n",
              "3           rs324640 7 GG  Corpo - Recuperação da frequência cardíaca apó...\n",
              "4          rs1572312 1 GT  Corpo - Resistência física - Predisposição par...\n",
              "5          rs2267668 6 AA  Corpo - Resposta ao exercício - Menor redução ...\n",
              "6          rs1042713 5 AA  Corpo/Fármaco - Capacidade cardiorrespiratória...\n",
              "7        rs17822931 16 CT  Curiosidade - Cera de ouvido - Predisposição p...\n",
              "8          rs1881396 2 TT  Curiosidade - Habilidade matemática - Sem pred...\n",
              "9          rs1726866 7 GG  Curiosidade - Percepção do gosto amargo - Pred...\n",
              "10          rs324420 1 CC  Curiosidade - Predisposição ao alcoolismo - Se...\n",
              "11         rs1801260 4 AA  Curiosidade - Preferência por horários - Predi...\n",
              "12       rs16969968 15 GG  Curiosidade - Propensão à dependência de nicot...\n",
              "13         rs634990 15 TT  Curiosidade - Visão - Risco padrão de desenvol...\n",
              "14         rs1799945 6 CG  Doenças Genéticas - Hemocromatose tipo 1 (vari...\n",
              "15        rs1057910 10 AC  Fármaco - Antiinflamatórios - Risco aumentado ...\n",
              "16           rs7412 19 CC  Fármaco - Atorvastatina (Lípitor®) - Resposta ...\n",
              "17         rs2297480 1 TT  Fármaco - Bisfosfonatos - Maior taxa de respos...\n",
              "18         rs4693075 4 CC  Fármaco - Estatinas - Sem predisposição para m...\n",
              "19       rs16960228 17 GG  Fármaco - Hidroclorotiazida (Clorana®) https:/...\n",
              "20       rs11212617 11 AA  Fármaco - Metformina (Glifage®) - Menor respos...\n",
              "21           rs4680 22 AA  Fármaco - Nicotina - Predisposição para abando...\n",
              "22           rs5443 12 CC  Fármaco - Sildenafil (Viagra®) - Chance padrão...\n",
              "23        rs10306114 9 AA  Fármaco - Ácido acetilsalicílico (Aspirina Pre...\n",
              "24          rs730012 5 AC  Fármaco - Ácido acetilsalicílico (Aspirina®) -...\n",
              "25         rs755017 20 AG  Idade - Comprimento dos telômeros - Predisposi...\n",
              "26       rs10490924 10 GG  Idade - Degeneração macular relacionada à idad...\n",
              "27         rs757110 11 CA  Idade - Diabetes tipo 2 - Predisposição para d...\n",
              "28        rs2075650 19 AA  Idade - Longevidade - Expectativa de vida mais...\n",
              "29        rs9652490 15 AG  Idade - Tremor essencial não relacionado a Par...\n",
              "30         rs1801282 3 CG  Nutrição - Eficácia da dieta mediterrânea / Ma...\n",
              "31        rs7903146 10 CC  Nutrição - Eficácia das dietas low fat e high ...\n",
              "32         rs1801133 1 GA  Nutrição - Folato (Vitamina B9) - Sem predispo...\n",
              "33            rs5400 3 GG  Nutrição - Ingestão de açúcares - Sem predispo...\n",
              "34        rs4822492 22 CG  Nutrição - Sensibilidade à cafeína - Sem predi...\n",
              "35         rs1800562 6 GG  Nutrição - Sobrecarga de ferro - Risco baixo h...\n",
              "36         rs1256335 1 AA  Nutrição - Vitamina B6 - Sem predisposição par...\n",
              "37            rs7041 4 CC  Nutrição - Vitamina D - Sem predisposição para...\n",
              "38           rs7294 16 CC  Nutrição - Vitamina K - Sem predisposição para...\n",
              "39        rs1800566 16 GG  Pele - Capacidade antioxidante - Maior capacid...\n",
              "40       rs16927253 10 CC  Pele - Flacidez palpebral - Risco aumentado pa...\n",
              "41        rs2228479 16 GG  Pele - Risco para hiperpigmentação da pele - S...\n",
              "42          rs702491 1 CC  Pele - Rugas faciais - Sem predisposição para ...\n",
              "43        rs1805008 16 CC  Pele - Sensibilidade ao sol - Menor predisposi...\n",
              "44         rs964184 11 CC  Pele - Vitamina E - Sem predisposição para nív..."
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-bad3f569-d6f8-40b3-8c4a-f141741bcc23\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>RSID+CHROMOSOME+RESULT</th>\n",
              "      <th>DISEASE</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>rs2707466 7 TT</td>\n",
              "      <td>Corpo - Densidade óssea (força dos ossos) - Pr...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>rs12722 9 CT</td>\n",
              "      <td>Corpo - Dor muscular pós-exercício - Maior dor...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>rs1800169 11 GG</td>\n",
              "      <td>Corpo - Força muscular - Predisposição para ma...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>rs324640 7 GG</td>\n",
              "      <td>Corpo - Recuperação da frequência cardíaca apó...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>rs1572312 1 GT</td>\n",
              "      <td>Corpo - Resistência física - Predisposição par...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>rs2267668 6 AA</td>\n",
              "      <td>Corpo - Resposta ao exercício - Menor redução ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>6</th>\n",
              "      <td>rs1042713 5 AA</td>\n",
              "      <td>Corpo/Fármaco - Capacidade cardiorrespiratória...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7</th>\n",
              "      <td>rs17822931 16 CT</td>\n",
              "      <td>Curiosidade - Cera de ouvido - Predisposição p...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>8</th>\n",
              "      <td>rs1881396 2 TT</td>\n",
              "      <td>Curiosidade - Habilidade matemática - Sem pred...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>9</th>\n",
              "      <td>rs1726866 7 GG</td>\n",
              "      <td>Curiosidade - Percepção do gosto amargo - Pred...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>10</th>\n",
              "      <td>rs324420 1 CC</td>\n",
              "      <td>Curiosidade - Predisposição ao alcoolismo - Se...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>11</th>\n",
              "      <td>rs1801260 4 AA</td>\n",
              "      <td>Curiosidade - Preferência por horários - Predi...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>12</th>\n",
              "      <td>rs16969968 15 GG</td>\n",
              "      <td>Curiosidade - Propensão à dependência de nicot...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>13</th>\n",
              "      <td>rs634990 15 TT</td>\n",
              "      <td>Curiosidade - Visão - Risco padrão de desenvol...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>14</th>\n",
              "      <td>rs1799945 6 CG</td>\n",
              "      <td>Doenças Genéticas - Hemocromatose tipo 1 (vari...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>15</th>\n",
              "      <td>rs1057910 10 AC</td>\n",
              "      <td>Fármaco - Antiinflamatórios - Risco aumentado ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>16</th>\n",
              "      <td>rs7412 19 CC</td>\n",
              "      <td>Fármaco - Atorvastatina (Lípitor®) - Resposta ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>17</th>\n",
              "      <td>rs2297480 1 TT</td>\n",
              "      <td>Fármaco - Bisfosfonatos - Maior taxa de respos...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>18</th>\n",
              "      <td>rs4693075 4 CC</td>\n",
              "      <td>Fármaco - Estatinas - Sem predisposição para m...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>19</th>\n",
              "      <td>rs16960228 17 GG</td>\n",
              "      <td>Fármaco - Hidroclorotiazida (Clorana®) https:/...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>20</th>\n",
              "      <td>rs11212617 11 AA</td>\n",
              "      <td>Fármaco - Metformina (Glifage®) - Menor respos...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>21</th>\n",
              "      <td>rs4680 22 AA</td>\n",
              "      <td>Fármaco - Nicotina - Predisposição para abando...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>22</th>\n",
              "      <td>rs5443 12 CC</td>\n",
              "      <td>Fármaco - Sildenafil (Viagra®) - Chance padrão...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>23</th>\n",
              "      <td>rs10306114 9 AA</td>\n",
              "      <td>Fármaco - Ácido acetilsalicílico (Aspirina Pre...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>24</th>\n",
              "      <td>rs730012 5 AC</td>\n",
              "      <td>Fármaco - Ácido acetilsalicílico (Aspirina®) -...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>25</th>\n",
              "      <td>rs755017 20 AG</td>\n",
              "      <td>Idade - Comprimento dos telômeros - Predisposi...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>26</th>\n",
              "      <td>rs10490924 10 GG</td>\n",
              "      <td>Idade - Degeneração macular relacionada à idad...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>27</th>\n",
              "      <td>rs757110 11 CA</td>\n",
              "      <td>Idade - Diabetes tipo 2 - Predisposição para d...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>28</th>\n",
              "      <td>rs2075650 19 AA</td>\n",
              "      <td>Idade - Longevidade - Expectativa de vida mais...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>29</th>\n",
              "      <td>rs9652490 15 AG</td>\n",
              "      <td>Idade - Tremor essencial não relacionado a Par...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>30</th>\n",
              "      <td>rs1801282 3 CG</td>\n",
              "      <td>Nutrição - Eficácia da dieta mediterrânea / Ma...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>31</th>\n",
              "      <td>rs7903146 10 CC</td>\n",
              "      <td>Nutrição - Eficácia das dietas low fat e high ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>32</th>\n",
              "      <td>rs1801133 1 GA</td>\n",
              "      <td>Nutrição - Folato (Vitamina B9) - Sem predispo...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>33</th>\n",
              "      <td>rs5400 3 GG</td>\n",
              "      <td>Nutrição - Ingestão de açúcares - Sem predispo...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>34</th>\n",
              "      <td>rs4822492 22 CG</td>\n",
              "      <td>Nutrição - Sensibilidade à cafeína - Sem predi...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>35</th>\n",
              "      <td>rs1800562 6 GG</td>\n",
              "      <td>Nutrição - Sobrecarga de ferro - Risco baixo h...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>36</th>\n",
              "      <td>rs1256335 1 AA</td>\n",
              "      <td>Nutrição - Vitamina B6 - Sem predisposição par...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>37</th>\n",
              "      <td>rs7041 4 CC</td>\n",
              "      <td>Nutrição - Vitamina D - Sem predisposição para...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>38</th>\n",
              "      <td>rs7294 16 CC</td>\n",
              "      <td>Nutrição - Vitamina K - Sem predisposição para...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>39</th>\n",
              "      <td>rs1800566 16 GG</td>\n",
              "      <td>Pele - Capacidade antioxidante - Maior capacid...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>40</th>\n",
              "      <td>rs16927253 10 CC</td>\n",
              "      <td>Pele - Flacidez palpebral - Risco aumentado pa...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>41</th>\n",
              "      <td>rs2228479 16 GG</td>\n",
              "      <td>Pele - Risco para hiperpigmentação da pele - S...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>42</th>\n",
              "      <td>rs702491 1 CC</td>\n",
              "      <td>Pele - Rugas faciais - Sem predisposição para ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>43</th>\n",
              "      <td>rs1805008 16 CC</td>\n",
              "      <td>Pele - Sensibilidade ao sol - Menor predisposi...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>44</th>\n",
              "      <td>rs964184 11 CC</td>\n",
              "      <td>Pele - Vitamina E - Sem predisposição para nív...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-bad3f569-d6f8-40b3-8c4a-f141741bcc23')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-bad3f569-d6f8-40b3-8c4a-f141741bcc23 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-bad3f569-d6f8-40b3-8c4a-f141741bcc23');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 3
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "9iaKAOLf26ZW"
      },
      "source": [
        "# Referências bibliográficas - DOENÇAS"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Doença de Wilson:\n",
        "CHANG, I. J.; HAHN, S. H. The genetics of Wilson disease. Handbook of Clinical Neurology, v.142, p. 9-34, 2017.\n",
        "\n",
        "MEDICI, V.; LASALLE, J. M.  Genetics and epigenetic factors of Wilson disease. Annals of Translational Medicine, v. 7, suppl 2,  p.1-12, 2019.\n",
        "\n",
        "Nomenclatura técnica: ATP7B(NM_000053.4): c.3207C>A; p.His1069Gln | Frequência: <1%\n",
        "\n",
        "## Deficiência de Alfa-1 Antitripsina (variante PI*Z):\n",
        "CRYSTAL, R. G. Alpha 1-Antitrypsin Deficiency, Emphysema, and Liver Disease. Genetic Basis and Strategies for Therapy. Journal of Clinical Investigation, v. 85, n. 5, p. 1343–52. 1990.\n",
        "\n",
        "TANASH, H.A., PIITULAINEN, E. Liver disease in adults with severe alpha-1-antitrypsin deficiency. Liver, pancreas and biliary tract. Journal of Gastroenterology. v. 54, p. 541–548. 2019. \n",
        "\n",
        "STOLLER, J. K., et al. Alpha-1 Antitrypsin Deficiency. Gene Reviews. University of Washington, Seattle: PubMed. 1993-2020.\n",
        "\n",
        "Nomenclatura Técnica: SERPINA1(NM_000295.5): c.1096G>A; p.Glu366Lys | Frequência: <1%\n",
        "\n",
        "## Deficiência de Alfa-1 Antitripsina (variante PI*S):\n",
        "CRYSTAL, R. G. Alpha 1-Antitrypsin Deficiency, Emphysema, and Liver Disease. Genetic Basis and Strategies for Therapy. Journal of Clinical Investigation, v. 85, n. 5, p. 1343–52. 1990.\n",
        "\n",
        "TANASH, H.A., PIITULAINEN, E. Liver disease in adults with severe alpha-1-antitrypsin deficiency. Liver, pancreas and biliary tract. Journal of Gastroenterology. v. 54, p. 541–548. 2019. \n",
        "\n",
        "STOLLER, J. K., et al. Alpha-1 Antitrypsin Deficiency. Gene Reviews. University of Washington, Seattle: PubMed. 1993-2020.\n",
        "\n",
        "Nomenclatura Técnica: SERPINA1(NC_000014.9): g.94380925T>A; p.Glu288Val | Frequência: <1%\n",
        "\n",
        "## Deficiência de fator XII:\n",
        "CALAFELL, F. et al. Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels. Human Molecular Genetics, v. 19, n. 3, p. 517-525, 2009.\n",
        "\n",
        "KANAJI, T. et al. A common genetic polymorphism (46 C to T substitution) in the 5'-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood, v. 91, n. 6, p. 2010-2014, 1998.\n",
        "\n",
        "REUNER, K. H. et al. Factor XII C46T gene polymorphism and the risk of cerebral venous thrombosis. Neurology, v. 70, n. 2, p. 70-72, 2008.\n",
        "\n",
        "Nomenclatura técnica:GRCh37 - NM_000505.4(F12):c.-4A>G | Frequência rs1801020-A = 35% \n",
        "\n",
        "## Trombofilia (Fator II - Protrombina):\n",
        "FIELDS, Madeline C.; LEVINE, Steven R. Thrombophilias and stroke: diagnosis, treatment, and prognosis. Journal of thrombosis and Thrombolysis, v. 20, n. 2, p. 113-126, 2005.  \n",
        "\n",
        "MANNUCCI, Pier Mannuccio; FRANCHINI, Massimo. Classic thrombophilic gene variants. Thrombosis and haemostasis, v. 114, n. 11, p. 885-889, 2015.  \n",
        "\n",
        "POORT, Swibertus R. et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. 1996.  \n",
        "\n",
        "ROSENDAAL, F. R. et al. Geographic distribution of the 20210 G to A prothrombin variant. Thrombosis and haemostasis, v. 79, n. 04, p. 706-708, 1998.  \n",
        "\n",
        "Nomenclatura técnica: F2 (NM_000506):c.*97G>A | Frequência rs1799963-A = < 1%\n",
        "\n",
        "## Trombofilia (Fator V de Leiden):\n",
        "FARAHMAND, K., TOTONCHI, M., HASHEMI, M. et al. Thrombophilic genes alterations as risk factor for recurrent pregnancy loss. J Matern Fetal Neonatal Med., 29(8), 1269-1273, 2016.\n",
        "\n",
        "BERTINA, R. M. et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature., 369(6475), 64-7, 1994.\n",
        "\n",
        "GERMAIN M. et al. Meta-analysis of 65,734 Individuals Identifies TSPAN15 and SLC44A2 as Two Susceptibility Loci for Venous Thromboembolism. Am J Hum Genet., 96(4), 532–542, 2015.\n",
        "\n",
        "HEIT J.A. et al. A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. J Thromb Haemost., 10(8): 1521–1531, 2012.\n",
        "\n",
        "KLARIN, D. et al. Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor. Circ Cardiovasc Genet, 10(2), 2017.\n",
        "\n",
        "KLARIN, D. et al. Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease. Nature genetics, 51(11), 1574-1579, 2019.\n",
        "\n",
        "LINDSTROM, S. et al. Genomic and Transcriptomic Association Studies Identify 16 Novel Susceptibility Loci for Venous Thromboembolism. Nat Genet., 51(11), 1574–1579, 2019.\n",
        "\n",
        "Nomenclatura técnica: F5(NC_000001.11): g.169549811C>T; p.Arg534Gln | Frequência: <1%\n",
        "\n",
        "## Hemocromatose tipo 1 (variante H63D):\n",
        "ALEXANDER, J.; KOWDLEY, K. V. HFE-associated hereditary hemochromatosis. Genetics in medicine, v. 11, n. 5, p. 307-313, 2009.  \n",
        "\n",
        "BARTON, J. C.; EDWARDS, C. Q.; ACTON, R. T. HFE gene: structure, function, mutations, and associated iron abnormalities. Gene, v. 574, n. 2, p. 179-192, 2015.  \n",
        "\n",
        "LIMDI, J. K.; CRAMPTON, J. R. Hereditary haemochromatosis. The Quarterly Journal of Medicine, v. 97, n. 6, p. 315-324, 2004.  \n",
        "\n",
        "Nomenclatura técnica: HFE(NM_000410.3):c.187C>G; p.His63Asp | Frequência: <1%\n",
        "\n",
        "## Hemocromatose tipo 1 (variante C282Y):\n",
        "ALEXANDER, J.; KOWDLEY, K. V. HFE-associated hereditary hemochromatosis. Genetics in Medicine, v. 11, n. 5, p. 307-313, 2009.\n",
        "\n",
        "BARTON, J. C.; EDWARDS, C. Q.; ACTON, R. T. HFE gene: structure, function, mutations, and associated iron abnormalities. Gene, v. 574, n. 2, p. 179-192, 2015.\n",
        "\n",
        "LIMDI, J. K.; CRAMPTON, J. R. Hereditary haemochromatosis. The Quarterly Journal of Medicine, v. 97, n. 6, p. 315-324, 2004.\n",
        "\n",
        "Nomenclatura técnica: HFE(NM_000410.3):c.845G>A; p.Cys282Tyr | Frequência: <1%\n",
        "\n",
        "## Hemocromatose tipo 1 (variante S65C):\n",
        "ALEXANDER, J.; KOWDLEY, K. V. HFE-associated hereditary hemochromatosis. Genetics in Medicine, v. 11, n. 5, p. 307-313, 2009.\n",
        "\n",
        "BARTON, J. C.; EDWARDS, C. Q.; ACTON, R. T. HFE gene: structure, function, mutations, and associated iron abnormalities. Gene, v. 574, n. 2, p. 179-192, 2015.\n",
        "\n",
        "LIMDI, J. K.; CRAMPTON, J. R. Hereditary haemochromatosis. The Quarterly Journal of Medicine, v. 97, n. 6, p. 315-324, 2004.\n",
        "\n",
        "Nomenclatura técnica: HFE(NM_000410.3):c.193A>T; p.Ser65Cys | Frequência: < 1%\n",
        "\n",
        "## Infarto do miocárdio:\n",
        "ANDERSON, Jeffrey L.; MORROW, David A. Acute myocardial infarction. New England Journal of Medicine, 2017, 376.21: 2053-2064.  \n",
        "\n",
        "FLOYD, Christopher N.; MUSTAFA, Agnesa; FERRO, Albert. The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis. PLoS One, v. 9, n. 7, p.1-14, 2014.  \n",
        "\n",
        "WEISS, Ethan J. et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. New England Journal of Medicine, v. 334, n. 17, p. 1090-1094, 1996.  \n",
        "\n",
        "BRAY, Paul F. et al. The platelet PlA2 and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. The American Journal of Cardiology, v. 88, n. 4, p. 347–352, 2001.   \n",
        "\n",
        "Nomenclatura técnica: ITGB3(NM_000212.2):c.176T>C; p.Leu59Pro | Frequência rs5918-C : 12,1%\n",
        "\n",
        "## Doenças mieloproliferativas:\n",
        "BAXTER, E. Joanna et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. The Lancet, v. 365, n. 9464, p. 1054-1061, 2005.\n",
        "\n",
        "KRALOVICS, Robert et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. New England Journal of Medicine, v. 352, n. 17, p. 1779-1790, 2005.\n",
        "\n",
        "Nomenclatura técnica:GRCh37 - NM_004972(JAK2): c.1849G>T, p.Val617Phe | Frequência rs77375493-T = < 1%  \n",
        "\n",
        "## Amiloidose hereditária (variante V122I):\n",
        "ADAM, M. P. et al. Hereditary Transthyretin Amyloidosis. GeneReviews®.\n",
        "\n",
        "BUXBAUM, J. N.; RUBERG, F. L. Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans. Genetics in Medicine, v. 19, n. 7, p. 733-742, 2017.\n",
        "\n",
        "JACOBSON, D. R. et al. Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African–Americans. Amyloid, 22.3: 171-174, 2015.\n",
        "\n",
        "SCHMIDT, H. H. et al. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle & Nerve, v. 57, n. 5, p. 829-837, 2018.\n",
        "\n",
        "Nomenclatura técnica: TTR(NM_000371.4):c.424G>A; p.Val142Ile | Frequência: < 1%\n",
        "\n",
        "## Amiloidose hereditária (variante V50M):\n",
        "ADAMS, David; CAUQUIL, Cécile; LABEYRIE, Céline. Familial amyloid polyneuropathy. Current opinion in neurology, v. 30, n. 5, p. 481-489, 2017.\n",
        "\n",
        "ADAM, M. P. et al. Hereditary Transthyretin Amyloidosis. GeneReviews®.\n",
        "\n",
        "SCHMIDT, Hartmut H. et al. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle & Nerve, v. 57, n. 5, p. 829-837, 2018.\n",
        "\n",
        "Nomenclatura técnica: TTR(NM_000371.4):c.148G>A; p.Val50Met (também conhecida como p.Val30Met) | Frequência: < 1%\n",
        "\n",
        "## Amiloidose hereditária (variante T80A):\n",
        "ADAM, M. P. et al. Hereditary Transthyretin Amyloidosis. GeneReviews®.\n",
        "\n",
        "KOTANI, Nobuhiro et al. Transthyretin Thr60Ala Appalachian-type mutation in a Japanese family with familial amyloidotic polyneuropathy. Amyloid, v. 9, n. 1, p. 31-34, 2002.\n",
        "\n",
        "SATTIANAYAGAM, Prayman T. et al. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant. European heart journal, v. 33, n. 9, p. 1120-1127, 2012.\n",
        "\n",
        "REILLY, M. M.; STAUNTON, H.; HARDING, A. E. Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological study. Journal of Neurology, Neurosurgery & Psychiatry, v. 59, n. 1, p. 45-49, 1995.\n",
        "\n",
        "SCHMIDT, Hartmut H. et al. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle & Nerve, v. 57, n. 5, p. 829-837, 2018.\n",
        "\n",
        "Nomenclatura técnica: TTR(NM_000371.4): c.238A>G, p.Thr80Ala (também conhecida como p.Thr60Ala) | Frequência: < 1%\n",
        "\n",
        "## Polipose associada ao gene MUTYH (variante G396D):\n",
        "AL-TASSAN, Nada et al. Inherited variants of MYH associated with somatic G: C→ T: A mutations in colorectal tumors. Nature genetics, v. 30, n. 2, p. 227-232, 2002.  \n",
        "\n",
        "LUBBE, Steven J. et al. Clinical implications of the colorectal cancer risk associated with MUTYH mutation. Journal of Clinical Oncology, v. 27, n. 24, p. 3975-3980, 2009.  \n",
        "\n",
        "KIDAMBI, Trilokesh D. et al. Hereditary polyposis syndromes. Current treatment options in gastroenterology, v. 17, n. 4, p. 650-665, 2019.  \n",
        "\n",
        "ORPHANET. Polipose adenomatosa familiar. Disponível em: https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=PT&Expert=733 Acessado em: 12 jul. 2022 \n",
        "\n",
        "SHUSSMAN, Noam; WEXNER, Steven D. Colorectal polyps and polyposis syndromes. Gastroenterology report, v. 2, n. 1, p. 1-15, 2014.  \n",
        "\n",
        "Nomenclatura técnica: MUTYH(NM_001128425.1): c.1187C>T, p.Gly396Asp | Frequência rs36053993-T =  < 1%\n",
        "\n",
        "## Doença de Parkinson e Doença de Gaucher (gene GBA):\n",
        "SIDRANSKY, Ellen et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. New England Journal of Medicine, v. 361, n. 17, p. 1651-1661, 2009.\n",
        "\n",
        "GAN-OR, Ziv et al. Differential effects of severe vs mild GBA mutations on Parkinson disease. Neurology, v. 84, n. 9, p. 880-887, 2015.\n",
        "\n",
        "DAVIS, Albert A. et al. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression. Neurobiology of aging, v. 37, p. 209. e1-209. e7, 2016.\n",
        "\n",
        "Nomenclatura técnica: GBA(NM_000157.4): c.1226A>G, p.Asn409Ser (Também conhecida como Asn370Ser) | Frequência: < 1%\n",
        "\n",
        "## Doença de Parkinson (gene LRRK2):\n",
        "HEALY, D.G., FALCHI, M., O'SULLIVAN, S.S., et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol., v. 7, p. 583-590, 2008.\n",
        "\n",
        "LESAGE, S., PATIN, E., CONDROYER, C., et al. Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans. Hum Mol Genet, v. 19, nº10, p. 1998-2004, 2010.\n",
        "\n",
        "ZHANG, P., CHEN, Y., ZHANG, C. et al. Genetics of Parkinson’s disease and related disorders. Journal of Medical Genetics, v. 55, p. 73-80, 2017.\n",
        "\n",
        "Nomenclatura técnica: LRRK2(NM_198578.4): c.6055G>A; p.Gly2019Ser | Frequência: < 1%\n",
        "\n",
        "## Câncer:\n",
        "CYBULSKI, C. et al. CHEK2 Is a Multiorgan Cancer Susceptibility Gene. The American Journal Of Human Genetics, v. 75, n. 6, p.1131-1135, 2004.\n",
        "\n",
        "HAN, F.; GUO, C.; LIU, L.. The Effect of CHEK2 Variant I157T on Cancer Susceptibility: Evidence from a Meta-Analysis. Dna And Cell Biology, v. 32, n. 6, p.329-335, 2013.\n",
        "\n",
        "OBAZEE, O. et al. Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma. International Journal Of Cancer, v. 145, n. 3, p.686-693, 2019.\n",
        "\n",
        "WANG, Y.; DA, B.; YE, D. CHEK2 mutation and risk of prostate cancer: a systematic review and meta-analysis. International Journal of Clinical and Experimental Medicine, v. 8, n. 9, p.15708-15715, 2015.\n",
        "\n",
        "YANG, Y. et al. Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry. Ebiomedicine, v. 48, p.203-211, 2019.\n",
        "\n",
        "Nomenclatura técnica: CHEK2(NM_007194.4): c.470T>C; p.Ile157Thr | Frequência: <1%"
      ],
      "metadata": {
        "id": "lLgkNH11AoPI"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Referências bibliográficas - FARMACOS"
      ],
      "metadata": {
        "id": "Pazdmtf_ABMj"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Ácido acetilsalicílico (Aspirina®):\n",
        "MASTALERZ, L. et al. Familial aggregation of aspirin‐induced urticaria and leukotriene C4 synthase allelic variant. British Journal of Dermatology, v. 154, n. 2, p. 256-260, 2006. \n",
        "\n",
        "MASTALERZ, Lucyna et al. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. Journal of Allergy and Clinical Immunology, v. 113, n. 4, p. 771-775, 2004. \n",
        "\n",
        "NCBI. 2020. LTC4S Leukotriene C4 Synthase [Homo Sapiens (Human)] - Gene - NCBI. [online] Available at: [Accessed 13 March 2020].  \n",
        "\n",
        "Nível de evidência: Moderado\n",
        "\n",
        "Informações sobre níveis de evidência:  Foi utilizada a base de dados em farmacogenômica PharmGKB para a classificação de nível de evidência. Mais informações (em inglês): https://www.pharmgkb.org/page/clinAnnLevels \n",
        "\n",
        "## Ácido acetilsalicílico (Aspirina Prevent®):\n",
        "MAREE, A. O. et al. Cyclooxygenase‐1 haplotype modulates platelet response to aspirin. Journal of Thrombosis and Haemostasis, v. 3, n. 10, p. 2340-2345, 2005.  \n",
        "\n",
        "NCBI. 2020. PTGS1 Prostaglandin-Endoperoxide Synthase 1 [Homo Sapiens (Human)] - Gene - NCBI. [online] Available at: [Accessed 17 March 2020]. https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=5742 \n",
        "\n",
        "SCHRÖR, Karsten. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. In: Seminars in thrombosis and hemostasis. Copyright© 1997 by Thieme Medical Publishers, Inc., 1997. p. 349-356.  \n",
        "\n",
        "Informações sobre níveis de evidência:  Foi utilizada a base de dados em farmacogenômica PharmGKB para a classificação de nível de evidência. Mais informações (em inglês): https://www.pharmgkb.org/page/clinAnnLevels\n",
        "\n",
        "## Antiinflamatórios:\n",
        "Martínez, C., Blanco, G., Ladero, J., García-Martín, E., Taxonera, C., Gamito, F., Diaz-Rubio, M. and Agúndez, J. (2004). Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use. British Journal of Pharmacology, 141(2), pp.205-208. http://dx.doi.org/10.1038/sj.bjp.0705623 \n",
        "\n",
        "Muri, E. M. F., de Mello Sposito, M. M., & Metsavaht, L. (2009). Antiinflamatórios não-esteroidais e sua farmacologia local. Acta fisiátrica, 16(4), 186-190.\n",
        "\n",
        "NCBI. (2020). CYP2C9 orthologs. [online] Available at: https://www.ncbi.nlm.nih.gov/gene/1559/ortholog/?scope=9526 [Accessed 28 Feb. 2020].\n",
        "\n",
        "Informações sobre níveis de evidência:  Foi utilizada a base de dados em farmacogenômica PharmGKB para a classificação de nível de evidência. Mais informações (em inglês): https://www.pharmgkb.org/page/clinAnnLevels\n",
        "\n",
        "## Bisfosfonatos:\n",
        "Marini, F., Falchetti, A., Silvestri, S., Bagger, Y., Luzi, E., Tanini, A., Christiansen, C. and Brandi, M., 2008. Modulatory effect of farnesyl pyrophosphate synthase (FDPS)rs2297480polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis. Current Medical Research and Opinion, 24(9), pp.2609-2615. DOI: 10.1185/03007990802352894\n",
        "\n",
        "Drake, M., Clarke, B. and Khosla, S., 2008. Bisphosphonates: Mechanism of Action and Role in Clinical Practice. Mayo Clinic Proceedings, 83(9), pp.1032-1045. DOI: 10.4065/83.9.1032\n",
        "\n",
        "Informações sobre níveis de evidência:  Foi utilizada a base de dados em farmacogenômica PharmGKB para a classificação de nível de evidência. Mais informações (em inglês): https://www.pharmgkb.org/page/clinAnnLevels\n",
        "\n",
        "## Estatinas:\n",
        "OH, Jisun et al. Genetic determinants of statin intolerance. Lipids in health and disease, v. 6, n. 1, p. 1-5, 2007.   \n",
        "\n",
        "PUCCETTI, Luca; CIANI, Federica; AUTERI, Alberto. Genetic involvement in statins induced myopathy. Preliminary data from an observational case-control study. Atherosclerosis, v. 211, n. 1, p. 28-29, 2010.  \n",
        "\n",
        "NCBI.  COQ2 - coenzyme Q2, polyprenyltransferase.  Disponível em: https://www.ncbi.nlm.nih.gov/gene/27235/ortholog/?scope=7776. Acesso em: 28 fev. 2020. \n",
        "\n",
        "Informações sobre níveis de evidência:  Foi utilizada a base de dados em farmacogenômica PharmGKB para a classificação de nível de evidência. Mais informações (em inglês): https://www.pharmgkb.org/page/clinAnnLevels\n",
        "\n",
        "## Atorvastatina (Lípitor®):\n",
        "Thompson, J., Man, M., Johnson, K., Wood, L., Lira, M., Lloyd, D., Banerjee, P., Milos, P., Myrand, S., Paulauskis, J., Milad, M. and Sasiela, W. (2005). An association study of 43 SNPs in 16 candidate genes with atorvastatin response. The Pharmacogenomics Journal, 5(6), pp.352-358. DOI: 10.1038/sj.tpj.6500328 \n",
        "\n",
        "Mega, J., Morrow, D., Brown, A., Cannon, C. and Sabatine, M. (2009). Identification of Genetic Variants Associated With Response to Statin Therapy. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(9), pp.1310-1315. DOI: 10.1161/ATVBAHA.109.188474 \n",
        "\n",
        "Thompson, J., Hyde, C., Wood, L., Paciga, S., Hinds, D., Cox, D., Hovingh, G. and Kastelein, J. (2009). Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort. Circulation: Cardiovascular Genetics, 2(2), pp.173-181. DOI: 10.1161/CIRCGENETICS.108.818062\n",
        "\n",
        "Informações sobre níveis de evidência:  Foi utilizada a base de dados em farmacogenômica PharmGKB para a classificação de nível de evidência. Mais informações (em inglês): https://www.pharmgkb.org/page/clinAnnLevels\n",
        "\n",
        "## Sinvastatina (Zocor®):\n",
        "Pasanen, M., Neuvonen, M., Neuvonen, P. and Niemi, M. (2006). SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid. Pharmacogenetics and Genomics, 16(12), pp.873-879. http://dx.doi.org/10.1097/01.fpc.0000230416.82349.90 \n",
        "\n",
        "SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study. (2008). New England Journal of Medicine, 359(8), pp.789-799. http://dx.doi.org/10.1056/NEJMoa0801936 \n",
        "\n",
        "Brunham, L., Lansberg, P., Zhang, L., Miao, F., Carter, C., Hovingh, G., Visscher, H., Jukema, J., Stalenhoef, A., Ross, C., Carleton, B., Kastelein, J. and Hayden, M. (2011). Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin. The Pharmacogenomics Journal, 12(3), pp.233-237. http://dx.doi.org/10.1038/tpj.2010.92 \n",
        "\n",
        "NCBI. (2020). SLCO1B1 orthologs. [online] Available at: https://www.ncbi.nlm.nih.gov/gene/10599/ortholog/?scope=9347 [Accessed 28 Feb. 2020].\n",
        "\n",
        "Informações sobre níveis de evidência:  Foi utilizada a base de dados em farmacogenômica PharmGKB para a classificação de nível de evidência. Mais informações (em inglês): https://www.pharmgkb.org/page/clinAnnLevels\n",
        "\n",
        "## Hidroclorotiazida (Clorana®):\n",
        "Turner, S., Boerwinkle, E., O’Connell, J., Bailey, K., Gong, Y., Chapman, A., McDonough, C., Beitelshees, A., Schwartz, G., Gums, J., Padmanabhan, S., Hiltunen, T., Citterio, L., Donner, K., Hedner, T., Lanzani, C., Melander, O., Saarela, J., Ripatti, S., Wahlstrand, B., Manunta, P., Kontula, K., Dominiczak, A., Cooper-DeHoff, R. and Johnson, J., 2013. Genomic Association Analysis of Common Variants Influencing Antihypertensive Response to Hydrochlorothiazide. Hypertension, 62(2), pp.391-397. DOI: 10.1161/HYPERTENSIONAHA.111.00436 \n",
        "\n",
        "Informações sobre níveis de evidência:  Foi utilizada a base de dados em farmacogenômica PharmGKB para a classificação de nível de evidência. Mais informações (em inglês): https://www.pharmgkb.org/page/clinAnnLevels\n",
        "\n",
        "## Metformina (Glifage®):\n",
        "Pedersen, A., Stage, T., Glintborg, D., Andersen, M. and Christensen, M., 2017. The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial. Basic & Clinical Pharmacology & Toxicology, 122(2), pp.239-244. DOI: 10.1111/bcpt.12874\n",
        "\n",
        "Florez, J., Jablonski, K., Taylor, A., Mather, K., Horton, E., White, N., Barrett-Connor, E., Knowler, W., Shuldiner, A. and Pollin, T., 2012. The C Allele of ATM rs11212617 Does Not Associate With Metformin Response in the Diabetes Prevention Program. Diabetes Care, 35(9), pp.1864-1867. DOI: 10.2337/dc11-2301\n",
        "\n",
        "van Leeuwen, N., Nijpels, G., Becker, M., Deshmukh, H., Zhou, K., Stricker, B., Uitterlinden, A., Hofman, A., van ’t Riet, E., Palmer, C., Guigas, B., Slagboom, P., Durrington, P., Calle, R., Neil, A., Hitman, G., Livingstone, S., Colhoun, H., Holman, R., McCarthy, M., Dekker, J., ’t Hart, L. and Pearson, E., 2012. A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts. Diabetologia, 55(7), pp.1971-1977. DOI: 10.1007/s00125-012-2537-x\n",
        "\n",
        "Nature Genetics, 2010. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. 43(2), pp.117-120. DOI: 10.1038/ng.735\n",
        "\n",
        " Reference, G., 2020. ATM Gene. [online] Genetics Home Reference. Available at: [Accessed 17 March 2020].\n",
        "\n",
        "Informações sobre níveis de evidência:  Foi utilizada a base de dados em farmacogenômica PharmGKB para a classificação de nível de evidência. Mais informações (em inglês): https://www.pharmgkb.org/page/clinAnnLevels\n",
        "\n",
        "## Nicotina:\n",
        "CHOI, Hye Duck; SHIN, Wan Gyoon. Association between catechol-O-methyltransferase (COMT) Val/Met genotype and smoking cessation treatment with nicotine: a meta-analysis. Pharmacogenomics, v. 16, n. 16, p. 1879-1885, 2015.  \n",
        "\n",
        "Genetics Home Reference. (2020). COMT gene. [online] disponível em: https://ghr.nlm.nih.gov/gene/COMT#resources Acessado em: 6 Mar. 2020. \n",
        "\n",
        "JOHNSTONE, Elaine C. et al. Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiology Biomarkers & Prevention, v. 16, n. 6, p. 1065-1069, 2007.  \n",
        "\n",
        "MARTIN, Lea M.; SAYETTE, Michael A. A review of the effects of nicotine on social functioning. Experimental and clinical psychopharmacology, v. 26, n. 5, p. 425, 2018.  \n",
        "\n",
        "MUNAFÒ, Marcus R. et al. Association of COMT Val108/158Met genotype with smoking cessation. Pharmacogenetics and genomics, v. 18, n. 2, p. 121-128, 2008.  \n",
        "\n",
        "SUN, Hongqiang et al. Association of functional COMT Val108/Met polymorphism with smoking cessation in a nicotine replacement therapy. Journal of Neural Transmission, v. 119, n. 12, p. 1491-1498, 2012.  \n",
        "\n",
        "Informações sobre níveis de evidência:  Foi utilizada a base de dados em farmacogenômica PharmGKB para a classificação de nível de evidência. Mais informações (em inglês): https://www.pharmgkb.org/page/clinAnnLevels \n",
        "\n",
        "## Opioides:\n",
        "Genetics Home Reference. (2020). COMT gene. [online] Available at: https://ghr.nlm.nih.gov/gene/COMT#resources [Accessed 6 Mar. 2020]. \n",
        "\n",
        "Matic, M., Jongen, J., Elens, L., de Wildt, S., Tibboel, D., Sillevis Smitt, P. and van Schaik, R. (2017). Advanced cancer pain: the search for genetic factors correlated with interindividual variability in opioid requirement. Pharmacogenomics, 18(12), pp.1133-1142. DOI: 10.2217/pgs-2017-0060 \n",
        "\n",
        "Elens, L., Norman, E., Matic, M., Rane, A., Fellman, V. and van Schaik, R. (2016). Genetic Predisposition to Poor Opioid Response in Preterm Infants. Therapeutic Drug Monitoring, 38(4), pp.525-533. DOI: 10.1097/FTD.0000000000000301 \n",
        "\n",
        "De Gregori, M., Diatchenko, L., Ingelmo, P., Napolioni, V., Klepstad, P., Belfer, I., Molinaro, V., Garbin, G., Ranzani, G., Alberio, G., Normanno, M., Lovisari, F., Somaini, M., Govoni, S., Mura, E., Bugada, D., Niebel, T., Zorzetto, M., De Gregori, S., Molinaro, M., Fanelli, G. and Allegri, M. (2016). Human Genetic Variability Contributes to Postoperative Morphine Consumption. The Journal of Pain, 17(5), pp.628-636. DOI: 10.1016/j.jpain.2016.02.003\n",
        "\n",
        "Informações sobre níveis de evidência:  Foi utilizada a base de dados em farmacogenômica PharmGKB para a classificação de nível de evidência. Mais informações (em inglês): https://www.pharmgkb.org/page/clinAnnLevels\n",
        "\n",
        "## Salbutamol (Aerolin®) e Salmeterol (Serevent®):\n",
        "Turner, S., Francis, B., Vijverberg, S., Pino-Yanes, M., Maitland-van der Zee, A., Basu, K., Bignell, L., Mukhopadhyay, S., Tavendale, R., Palmer, C., Hawcutt, D., Pirmohamed, M., Burchard, E. and Lipworth, B. (2016). Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment. Journal of Allergy and Clinical Immunology, 138(1), pp.107-113.e5. DOI: 10.1016/j.jaci.2015.10.045 \n",
        "\n",
        "Zuurhout, M., Vijverberg, S., Raaijmakers, J., Koenderman, L., Postma, D., Koppelman, G. and Maitland-van der Zee, A. (2013). Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting β2-agonists: results of the pacman cohort. Pharmacogenomics, 14(16), pp.1965-1971. DOI: 10.2217/pgs.13.200 NCBI. (2020). \n",
        "\n",
        "Informações sobre níveis de evidência:  Foi utilizada a base de dados em farmacogenômica PharmGKB para a classificação de nível de evidência. Mais informações (em inglês): https://www.pharmgkb.org/page/clinAnnLevels\n",
        "\n",
        "## Sildenafil (Viagra®):\n",
        "SPERLING, H., EISENHARDT, A., VIRCHOW, S., HAUCK, E., LENK, S., PORST, H., STIEF, C., WETTERAUER, U., RÜBBEN, H., MÜLLER, N. and SIFFERT, W., 2003. Sildenafil Response is Influenced by the G Protein β3 Subunit Gnb3 C825t Polymorphism: A Pilot Study. Journal of Urology, 169(3), pp.1048-1051. DOI: 10.1097/01.ju.0000058369.72348.ba\n",
        "\n",
        "Informações sobre níveis de evidência:  Foi utilizada a base de dados em farmacogenômica PharmGKB para a classificação de nível de evidência. Mais informações (em inglês): https://www.pharmgkb.org/page/clinAnnLevels\n",
        "\n",
        "## Sulfonilureias:\n",
        "Sanchez-Ibarra, H., Reyes-Cortes, L., Jiang, X., Luna-Aguirre, C., Aguirre-Trevino, D., Morales-Alvarado, I., Leon-Cachon, R., Lavalle-Gonzalez, F., Morcos, F. and Barrera-Saldaña, H. (2018). Genotypic and Phenotypic Factors Influencing Drug Response in Mexican Patients With Type 2 Diabetes Mellitus. Frontiers in Pharmacology, 9. DOI: 10.3389/fphar.2018.00320 \n",
        "\n",
        "Li, Q., Chen, M., Zhang, R., Jiang, F., Wang, J., Zhou, J., Bao, Y., Hu, C. and Jia, W. (2014). KCNJ11E23K variant is associated with the therapeutic effect of sulphonylureas in Chinese type 2 diabetic patients. Clinical and Experimental Pharmacology and Physiology, 41(10), pp.748-754. DOI: 10.1111/1440-1681.12280  \n",
        "\n",
        "Klen, J., Dolžan, V. and Janež, A. (2014). CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients. European Journal of Clinical Pharmacology, 70(4), pp.421-428. DOI: 10.1007/s00228-014-1641-x \n",
        "\n",
        "Javorsky, M., Klimcakova, L., Schroner, Z., Zidzik, J., Babjakova, E., Fabianova, M., Kozarova, M., Tkacova, R., Salagovic, J. and Tkac, I. (2012). KCNJ11 gene E23K variant and therapeutic response to sulfonylureas. European Journal of Internal Medicine, 23(3), pp.245-249. DOI: 10.1016/j.ejim.2011.10.018  \n",
        "\n",
        "Informações sobre níveis de evidência:  Foi utilizada a base de dados em farmacogenômica PharmGKB para a classificação de nível de evidência. Mais informações (em inglês): https://www.pharmgkb.org/page/clinAnnLevels"
      ],
      "metadata": {
        "id": "p8n80FCzAjLa"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Referências bibliográficas - NUTRIÇÃO"
      ],
      "metadata": {
        "id": "0B8WfzZoQTbK"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Vitamina B6:\n",
        "LOOHUIS, Loes et al. The Alkaline Phosphatase (ALPL) Locus Is Associated with B6 Vitamer Levels in CSF and Plasma. Genes, v. 10, n. 1, p.8-21, 2019. \n",
        "\n",
        "HAZRA, Aditi et al. Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Human Molecular Genetics, v. 18, n. 23, p.4677-4687, 2009.\n",
        "\n",
        "## Vitamina K:\n",
        "CROSIER, Michael D. et al. Association of sequence variations in vitamin K epoxide reductase and γ-glutamyl carboxylase genes with biochemical measures of vitamin K status. Journal of nutritional science and vitaminology, v. 55, n. 2, p. 112-119, 2009.  \n",
        "\n",
        "FUSARO, Maria et al. Vitamin K and osteoporosis. Nutrients, v. 12, n. 12, p. 3625, 2020.  \n",
        "\n",
        "## Intolerância à lactose:\n",
        "ENATTAH, Nabil Sabri et al. Identification of a variant associated with adult-type hypolactasia. Nature genetics, v. 30, n. 2, p. 233-237, 2002.  \n",
        "\n",
        "MATTAR, Rejane et al. LCT-22018G> A single nucleotide polymorphism is a better predictor of adult-type hypolactasia/lactase persistence in Japanese-Brazilians than LCT-13910C> T. Clinics, v. 65, p. 1399-1399, 2010.  \n",
        "\n",
        "MISSELWITZ, Benjamin et al. Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management. Gut, v. 68, n. 11, p. 2080-2091, 2019.  \n",
        "\n",
        "## Vitamina D:\n",
        "AHN, Jiyoung et al. Genome-wide association study of circulating vitamin D levels. Human Molecular Genetics, v. 19, n. 13, p. 2739-2745, 2010. \n",
        "\n",
        "AL-DAGHRI, Nasser M. et al. Efficacy of vitamin D supplementation according to vitamin D-binding protein polymorphisms. Nutrition, v. 63, p. 148-154, 2019. \n",
        "\n",
        "MCGRATH, John J. et al. A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. The Journal Of Steroid Biochemistry And Molecular Biology, v. 121, n. 1-2, p. 471-477, 2010.\n",
        "\n",
        "## Sensibilidade à cafeína:\n",
        "CHILDS, Emma et al. Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety. Neuropsychopharmacology, v. 33, n. 12, p.2791-2800, 2008.  \n",
        "\n",
        "HOHOFF, Christa et al. Adenosine A2A receptor gene: Evidence for association of risk variants with panic disorder and anxious personality. Journal Of Psychiatric Research, v. 44, n. 14, p.930-937, 2010.  \n",
        "\n",
        "## Eficácia da dieta mediterrânea:\n",
        "GARAULET, Marta et al. PPARγ Pro12Ala interacts with fat intake for obesity and weight loss in a behavioural treatment based on the Mediterranean diet. Molecular Nutrition & Food Research, v. 55, n. 12, p.1771-1779, 2011. \n",
        "\n",
        "LINDI, V. I. et al. Association of the Pro12Ala Polymorphism in the PPAR- 2 Gene With 3-Year Incidence of Type 2 Diabetes and Body Weight Change in the Finnish Diabetes Prevention Study. Diabetes, v. 51, n. 8, p.2581-2586, 2002. \n",
        "\n",
        "ANGELIS, Rebeca Carlota de. Novos conceitos em nutrição: reflexões a respeito do elo dieta e saúde. Arquivos de Gastroenterologia, v. 38, n. 4, p.269-271, 2001. \n",
        "\n",
        "## Fome emocional:\n",
        "CASTELLINI, Giovanni et al. Fat mass and obesity-associated gene (FTO) is associated to eating disorders susceptibility and moderates the expression of psychopathological traits. Plos One, v. 12, n. 3, p.e0173560, 2017.  \n",
        "\n",
        "WIEMERSLAGE, Lyle et al. An obesity-associated risk allele within theFTOgene affects human brain activity for areas important for emotion, impulse control and reward in response to food images. European Journal Of Neuroscience, , v. 43, n. 9, p.1173-1180, 2016.  \n",
        "\n",
        "## Eficácia das dietas low fat e high fat:\n",
        "GRAU, Katrine et al. TCF7L2 rs7903146–macronutrient interaction in obese individuals’ responses to a 10-wk randomized hypoenergetic diet. The American journal of clinical nutrition, v. 91, n. 2, p. 472-479, 2010.  \n",
        "\n",
        "GRANT, Struan FA et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature genetics, v. 38, n. 3, p. 320-323, 2006.  \n",
        "\n",
        "PILGAARD, K. et al. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia, v. 52, n. 7, p. 1298-1307, 2009.  \n",
        "\n",
        "## Eficácia da dieta low carb:\n",
        "SONESTEDT, Emily et al. Fat and carbohydrate intake modify the association between genetic variation in the FTO genotype and obesity. The American journal of clinical nutrition, v. 90, n. 5, p. 1418-1425, 2009.  \n",
        "\n",
        "## Manutenção de resultados após intervenção para perda de peso:\n",
        "DELAHANTY, L. M. et al. Genetic Predictors of Weight Loss and Weight Regain After Intensive Lifestyle Modification, Metformin Treatment, or Standard Care in the Diabetes Prevention Program. Diabetes Care, [s.l.], v. 35, n. 2, p.363-366, 16 dez. 2011. American Diabetes Association. http://dx.doi.org/10.2337/dc11-1328.\n",
        "\n",
        "NICKLAS, B. J. et al. Genetic Variation in the Peroxisome Proliferator-Activated Receptor- 2 Gene (Pro12Ala) Affects Metabolic Responses to Weight Loss and Subsequent Weight Regain. Diabetes, [s.l.], v. 50, n. 9, p.2172-2176, 1 set. 2001. American Diabetes Association. http://dx.doi.org/10.2337/diabetes.50.9.2172.\n",
        "\n",
        "FRANKS, P. W. et al. The Pro12Ala variant at the peroxisome proliferator-activated receptor γ gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia, [s.l.], v. 50, n. 12, p.2451-2460, 27 set. 2007. Springer Science and Business Media LLC. http://dx.doi.org/10.1007/s00125-007-0826-6.\n",
        "\n",
        "## Ingestão de açúcares:\n",
        "ENY, Karen M. et al. Genetic variant in the glucose transporter type 2 is associated with higher intakes of sugars in two distinct populations. Physiological Genomics, v. 33, n. 3, p.355-360, 2008. \n",
        "\n",
        "HOLLA, Lydie Izakovicova et al. GLUT2 and TAS1R2 Polymorphisms and Susceptibility to Dental Caries. Caries Research, v. 49, n. 4, p.417-424, 2015.\n",
        "\n",
        "## Armazenamento de gordura:\n",
        "CLAUSSNITZER, Melina et al. FTO obesity variant circuitry and adipocyte browning in humans. New England Journal of Medicine, v. 373, n. 10, p. 895-907, 2015. \n",
        "\n",
        "BARTELT, Alexander; HEEREN, Joerg. Adipose tissue browning and metabolic health. Nature Reviews Endocrinology, v. 10, n. 1, p. 24-36, 2014. \n",
        "\n",
        "VIRTANEN, Kirsi A. et al. Functional brown adipose tissue in healthy adults. New England Journal of Medicine, v. 360, n. 15, p. 1518-1525, 2009.\n",
        "\n",
        "## Folato (Vitamina B9):\n",
        "CZEIZEL, Andrew E. et al. Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects. Nutrients, v. 5, n. 11, p. 4760-4775, 2013.  \n",
        "\n",
        "LEVIN, Brooke Levenseller; VARGA, Elizabeth. MTHFR: addressing genetic counseling dilemmas using evidence-based literature. Journal of genetic counseling, v. 25, n. 5, p. 901-911, 2016.  \n",
        "\n",
        "THOMAS, Philip; FENECH, Michael. Methylenetetrahydrofolate reductase, common polymorphisms, and relation to disease. Vitamins & Hormones, v. 79, p. 375-392, 2008.  \n",
        "\n",
        "## Sobrecarga de ferro:\n",
        "WITTE, David L. et al. Hereditary hemochromatosis. Clinica Chimica Acta, [s.l.], v. 245, n. 2, p.139-200, fev. 1996. Elsevier BV. http://dx.doi.org/10.1016/0009-8981(95)06212-2.\n",
        "\n",
        "GALLEGO, Carlos J. et al. Penetrance of Hemochromatosis in HFE Genotypes Resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE Network. The American Journal Of Human Genetics, [s.l.], v. 97, n. 4, p.512-520, out. 2015. Elsevier BV. http://dx.doi.org/10.1016/j.ajhg.2015.08.008.\n",
        "\n",
        "KATSAROU, Martha-Spyridoula et al. Population-based analysis of the frequency of HFE gene polymorphisms: Correlation with the susceptibility to develop hereditary hemochromatosis. Molecular Medicine Reports, [s.l.], v. 14, n. 1, p.630-636, 20 maio 2016. Spandidos Publications. http://dx.doi.org/10.3892/mmr.2016.5317.\n",
        "\n",
        "## Sensação de saciedade:\n",
        "DEN HOED, Marcel et al. Postprandial responses in hunger and satiety are associated with the rs9939609 single nucleotide polymorphism in FTO. The American journal of clinical nutrition, v. 90, n. 5, p. 1426-1432, 2009. \n",
        "\n",
        "DOUGKAS, Anestis et al. The impact of obesity-related SNP on appetite and energy intake. British journal of nutrition, v. 110, n. 6, p. 1151-1156, 2013. \n",
        "\n",
        "WARDLE, Jane et al. Obesity associated genetic variation in FTO is associated with diminished satiety. The Journal of Clinical Endocrinology & Metabolism, v. 93, n. 9, p. 3640-3643, 2008. \n",
        "\n",
        "WARDLE, J. et al. The FTO gene and measured food intake in children. International journal of obesity, v. 33, n. 1, p. 42-45, 2009."
      ],
      "metadata": {
        "id": "-5dNa10yQguw"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Referências bibliográficas - CORPO"
      ],
      "metadata": {
        "id": "ffiRygfyV4Jj"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Resistência física:\n",
        "AHMETOV, Ildus et al. Genome-wide association study identifies three novel genetic markers associated with elite endurance performance. Biology Of Sport, v. 32, n. 1, p.3-9, 2014.\n",
        "\n",
        "## Performance atlética:\n",
        "CORRÊA, Daniel Kroeff de Araujo, et al. Excelência na produtividade: a performance dos jogadores de futebol profissional. Psicologia: reflexão e crítica, 2002, 15: 447-460.  \n",
        "\n",
        "SANTIAGO, Catalina, et al. ACTN3 genotype in professional soccer players. British journal of sports medicine, 2008, 42.1: 71-73.   \n",
        "\n",
        "YANG, Nan, et al. ACTN3 genotype is associated with human elite athletic performance. The American Journal of human genetics, 2003, 73.3: 627-631.  \n",
        "\n",
        "## Danos musculares induzidos pela prática de atividade física:\n",
        "AHMETOV, I. I., et al. SOD2 gene polymorphism and muscle damage markers in elite athletes. Free Radical Research, v. 48, n.8, p. 948-955, 2014.\n",
        "\n",
        "AKIMOTO, Arthur Kenji et al. Evaluation of gene polymorphisms in exercise-induced oxidative stress and damage. Free Radical Research, v. 44, n. 3, p.322-331, 2010.  \n",
        "\n",
        "BAUMERT, Philipp et al. Genetic variation and exercise-induced muscle damage: implications for athletic performance, injury and ageing. European Journal Of Applied Physiology, v. 116, n. 9, p.1595-1625, 2016.    \n",
        "\n",
        "BEN-ZAKEN, S., et al. Increased prevalence of MnSOD genetic polymorphism in endurance and power athletes. Free radical research, v. 47, n. 12, p. 1002-1008, 2013.  \n",
        "\n",
        "## Densidade óssea (força dos ossos):\n",
        "GARCIA-IBARBIA, C., et al. Missense polymorphisms of the WNT16 gene are associated with bone mass, hip geometry and fractures. Osteoporosis International, 2013, 24.9: 2449-2454.  \n",
        "\n",
        "NASCIMENTO, Thales Boaventura Rachid; GLANER, Maria Fátima; PACCINI, Marina Kanthack. Influência da composição corporal e da idade sobre a densidade óssea em relação aos níveis de atividade física. Arquivos Brasileiros de Endocrinologia & Metabologia, 2009, 53: 440-445.  \n",
        "\n",
        "ZHENG, Hou-Feng, et al. WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk. PLoS genetics, 2012, 8.7: e1002745.   \n",
        "\n",
        "## Risco de obesidade:\n",
        "O gene FTO está associado à sensação de saciedade e ao estímulo do apetite. Uma variante alélica (A) deste gene está relacionada a um maior IMC e maior risco de obesidade em diversas populações.\n",
        "\n",
        "## Resposta ao exercício:\n",
        "LEOŃSKA-DUNIEC, Agata et al. The polymorphisms of the PPARD gene modify post-training body mass and biochemical parameter changes in women. Plos One, [s.l.], v. 13, n. 8, p. e0202557, 29 ago. 2018. Public Library of Science (PLoS). http://dx.doi.org/10.1371/journal.pone.0202557.\n",
        "\n",
        "THAMER, Claus et al. Variations in PPARD Determine the Change in Body Composition during Lifestyle Intervention: A Whole-Body Magnetic Resonance Study. The Journal Of Clinical Endocrinology & Metabolism, [s.l.], v. 93, n. 4, p.1497-1500, abr. 2008. The Endocrine Society. http://dx.doi.org/10.1210/jc.2007-1209.\n",
        "\n",
        "## Ganho de massa muscular:\n",
        "LEOŃSKA-DUNIEC, Agata et al. The polymorphisms of the PPARD gene modify post-training body mass and biochemical parameter changes in women. PLoS One, v. 13, n. 8, p. e0202557, 2018.   \n",
        "\n",
        "THAMER, Claus et al. Variations in PPARD determine the change in body composition during lifestyle intervention: a whole-body magnetic resonance study. The Journal of Clinical Endocrinology & Metabolism, v. 93, n. 4, p. 1497-1500, 2008.   \n",
        "\n",
        "## Índice de massa corporal (IMC):\n",
        "FRAYLING, T. M. et al. A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity. Science, v. 316, n. 5826, p.889-894, 2007. \n",
        "\n",
        "REUTER, Cézane Priscila et al. Associação entre sobrepeso e obesidade em escolares com o polimorfismo rs9939609 (FTO) e histórico familiar de obesidade. Jornal de Pediatria, v. 92, n. 5, p.493-498, 2016. \n",
        "\n",
        "LIMA, William Alves; GLANER, Maria Fátima; TAYLOR, Aline Pic. Fenótipo da gordura, fatores associados e o polimorfismo rs9939609 do gene FTO. Revista Brasileira de Cineantropometria e Desempenho Humano, v. 12, n. 2, p.164-172, 2011.\n",
        "\n",
        "## Força muscular:\n",
        "ARKING, Dan E. et al. Variation in the ciliary neurotrophic factor gene and muscle strength in older Caucasian women.Journal of the American Geriatrics Society, v. 54, n. 5, p. 823-826, 2006.  \n",
        "\n",
        "ROTH, Stephen M. et al. CNTF genotype is associated with muscular strength and quality in humans across the adult age span. Journal of applied physiology, v. 90, n. 4, p. 1205-1210, 2001.  \n",
        "\n",
        "## Tendinopatia de Aquiles:\n",
        "RALEIGH, S M et al. Variants within the MMP3 gene are associated with Achilles tendinopathy: possible interaction with the COL5A1 gene. British Journal Of Sports Medicine, [s.l.], v. 43, n. 7, p.514-520, 28 nov. 2008. BMJ. http://dx.doi.org/10.1136/bjsm.2008.053892.\n",
        "\n",
        "## Capacidade cardiorrespiratória:\n",
        "WOLFARTH, Bernd et al. Association between a beta2-adrenergic receptor polymorphism and elite endurance performance. Metabolism, v. 56, n. 12, p. 1649-1651, 2007.\n",
        "\n",
        "WAGONER, Lynne E. et al. Polymorphisms of the beta2-adrenergic receptor determine exercise capacity in patients with heart failure. Circulation research, v. 86, n. 8, p. 834-840, 2000.\n",
        "\n",
        "TSIANOS, Georgios I. et al. Associations of polymorphisms of eight muscle-or metabolism-related genes with performance in Mount Olympus marathon runners. Journal of applied physiology, v. 108, n. 3, p. 567-574, 2009.\n",
        "\n",
        "## Resistência muscular:\n",
        "AHMETOV, Ildus I. et al. The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes. Human genetics, v. 126, n. 6, p. 751-761, 2009.  \n",
        "\n",
        "LOPEZ-LEON, Sandra; TUVBLAD, Catherine; FORERO, D. A. Sports genetics: the PPARA gene and athletes’ high ability in endurance sports. A systematic review and meta-analysis. Biology of sport, v. 33, n. 1, p. 3-6, 2016.  \n",
        "\n",
        "## Recuperação da frequência cardíaca após exercício físico:\n",
        "HAUTALA, Arto J. et al. Heart rate recovery after maximal exercise is associated with acetylcholine receptor M2 (CHRM2) gene polymorphism. American Journal of Physiology-Heart and Circulatory Physiology, v. 291, n. 1, p. H459-H466, 2006.  \n",
        "\n",
        "VAN DE VEGTE, Yordi J. et al. Genetics and the heart rate response to exercise. Cellular and molecular life sciences, v. 76, n. 12, p. 2391-2409, 2019.  \n",
        "\n",
        "## Dor muscular pós-exercício:\n",
        "BAUMERT, P. et al. Variations of collagen-encoding genes are associated with exercise-induced muscle damage. Physiological Genomics, [s.l.], v. 50, n. 9, p.691-693, 1 set. 2018. American Physiological Society. http://dx.doi.org/10.1152/physiolgenomics.00145.2017.\n",
        "\n",
        "BAUMERT, P. et al. Genetic variation and exercise-induced muscle damage: implications for athletic performance, injury and ageing. European Journal Of Applied Physiology, [s.l.], v. 116, n. 9, p.1595-1625, 13 jun. 2016. Springer Science and Business Media LLC. http://dx.doi.org/10.1007/s00421-016-3411-1."
      ],
      "metadata": {
        "id": "TolgbTx1WRcX"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Referências bibliográficas - PELE"
      ],
      "metadata": {
        "id": "M75rQSRLV8dB"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Sensibilidade ao sol:\n",
        "ABDEL‐MALEK, Zalfa A. et al. The melanocortin 1 receptor and the UV response of human melanocytes—a shift in paradigm. Photochemistry and photobiology, v. 84, n. 2, p. 501-508, 2008.  \n",
        "\n",
        "SULEM, Patrick et al. Genetic determinants of hair, eye and skin pigmentation in Europeans. Nature genetics, v. 39, n. 12, p. 1443-1452, 2007.  \n",
        "\n",
        "## Acne:\n",
        "LEUNG, Alexander KC et al. Dermatology: how to manage acne vulgaris. Drugs in context, v. 10, 2021.  \n",
        "\n",
        "WANG, HongYan et al. Variants in SELL, MRPS 36P2, TP 63, DDB 2, CACNA 1H, ADAM 19, GNAI 1, CDH 13 and GABRG 2 interact to confer risk of acne in Chinese population. The Journal of dermatology, v. 42, n. 4, p. 378-381, 2015.  \n",
        "\n",
        "## Deficiência de Vitamina C:\n",
        "DUELL, Eric J. et al. Vitamin C transporter gene (SLC23A1 and SLC23A2) polymorphisms, plasma vitamin C levels, and gastric cancer risk in the EPIC cohort. Genes & Nutrition, v. 8, n. 6, p.549-560, 2013. Springer Nature.  \n",
        "\n",
        "TIMPSON, Nicholas J et al. Genetic variation at the SLC23A1 locus is associated with circulating concentrations of l-ascorbic acid (vitamin C): evidence from 5 independent studies with >15,000 participants. The American Journal Of Clinical Nutrition, v. 92, n. 2, p.375-382, 2010.   \n",
        "\n",
        "## Vitamina E:\n",
        "MAJOR, Jacqueline M. et al. Genome-wide association study identifies common variants associated with circulating vitamin E levels. Human molecular genetics, v. 20, n. 19, p. 3876-3883, 2011. \n",
        "\n",
        "ZAFFARIN, Anis Syauqina Mohd et al. Pharmacology and pharmacokinetics of vitamin E: Nanoformulations to enhance bioavailability. International journal of nanomedicine, v. 15, p. 9961, 2020.\n",
        "\n",
        "## Capacidade antioxidante:\n",
        "NAVAL, Jordi; ALONSO, Vicente; HERRANZ, Miquel Angel. Genetic polymorphisms and skin aging: the identification of population genotypic groups holds potential for personalized treatments. Clinical, Cosmetic And Investigational Dermatology, p.207-214, 2014.\n",
        "\n",
        "## Risco para hiperpigmentação da pele:\n",
        "ELFAKIR, Anissa et al. Functional MC1R-Gene Variants Are Associated with Increased Risk for Severe Photoaging of Facial Skin. Journal of Investigative Dermatology, v. 130, p. 1107–1115, 2010. \n",
        "\n",
        "LATREILLE, Julie et al. MC1R Gene Polymorphism Affects Skin Color and Phenotypic Features Related to Sun Sensitivity in a Population of French Adult Women. Photochemistry and Photobiology, n. 85, p. 1451–1458, 2009. \n",
        "\n",
        "MOTOKAWA, Tomonori et al. Effect of Val92Met and Arg163Gln variants of the MC1R gene on freckles and solar lentigines in Japanese. Pigment cell research, v. 20, n. 2, p. 140-143, 2007.\n",
        "\n",
        "SHIN, Joong-Gon et al. Genome-wide association analysis of 17,019 Korean women identifies variants associated with facial pigmented spots. The Journal of Investigative Dermatology, 2020. \n",
        "\n",
        "SURYANINGSIH, Betty Ekawati et al. Association between heterozygote Val92Met MC1R gene polymorphisms with incidence of melasma: a study of Javanese women population in Yogyakarta. Clinical, cosmetic and investigational dermatology, v. 12, p. 489, 2019. \n",
        "\n",
        "## Rugas faciais:\n",
        "GUNN, D. A. et al. Why some women look young for their age. PLoS One. 2009. \n",
        "\n",
        "HAMER, M. A. et al. Facial Wrinkles in Europeans: A Genome-Wide Association Study. Journal of Investigative Dermatology, v. 138, p. 1877-1880, 2018.\n",
        "\n",
        "## Flacidez palpebral:\n",
        "Laville, V., et al. \"A genome wide association study identifies new genes potentially associated with eyelid sagging\". Exp Dermatol. (2019) ;28(8):892-898."
      ],
      "metadata": {
        "id": "pEG6Zg8aWZUx"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Referências bibliográficas - IDADE"
      ],
      "metadata": {
        "id": "3zL3gl9YV86I"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Fotoenvelhecimento:\n",
        "CHEN, Xi; YANG, Chunsheng; JIANG, Guan. Research progress on skin photoaging and oxidative stress. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, v. 38, n. 6, p. 931-936, 2021.  \n",
        "\n",
        "LE CLERC, Sigrid et al. A genome-wide association study in Caucasian women points out a putative role of the STXBP5L gene in facial photoaging. Journal of Investigative Dermatology, v. 133, n. 4, p. 929-935, 2013.  \n",
        "\n",
        "## Calvície:\n",
        "LI, Rui et al. Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases. PLoS genetics, v. 8, n. 5, p. e1002746, 2012.  \n",
        "\n",
        "RAMOS, Paulo Müller; MIOT, Hélio Amante. Female pattern hair loss: a clinical and pathophysiological review. Anais brasileiros de dermatologia, v. 90, p. 529-543, 2015. \n",
        "\n",
        "## Diabetes tipo 2:\n",
        "BAKHTIYARI, A. et al. Association between ABCC8 Ala1369Ser Polymorphism (rs757110 T/G) and Type 2 Diabetes risk in an Iranian population: a case-control study. Endocrine, Metabolic & Immune Disorders - Drug Targets, v. 20, jul. 2020.  \n",
        "\n",
        "VIJI, D. et al. Genetic association of ABCC8 rs757110 polymorphism with Type 2 Diabetes Mellitus risk: A case-control study in South India and a meta-analysis. Gene Reports, v. 13, p.220-228, dez. 2018.  \n",
        "\n",
        "VIJAN, Sandeep. In the clinic. Type 2 diabetes. Annals of internal medicine, v. 162, n. 5, p. ITC1-16, 2015.  \n",
        "\n",
        "## Longevidade:\n",
        "DEELEN, Joris et al. Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited. Aging Cell, [s.l.], v. 10, n. 4, p.686-698, 6 maio 2011. Wiley. http://dx.doi.org/10.1111/j.1474-9726.2011.00705.x.\n",
        "\n",
        "SEBASTIANI, Paola et al. Meta-analysis of genetic variants associated with human exceptional longevity. Aging, [s.l.], v. 5, n. 9, p.653-661, 24 ago. 2013. Impact Journals, LLC. http://dx.doi.org/10.18632/aging.100594.\n",
        "\n",
        "SEBASTIANI, Paola et al. APOE Alleles and Extreme Human Longevity. The Journals Of Gerontology: Series A, [s.l.], v. 74, n. 1, p.44-51, 27 jul. 2018. Oxford University Press (OUP). http://dx.doi.org/10.1093/gerona/gly174.\n",
        "\n",
        "## Comprimento dos telômeros:\n",
        "CCODD, Veryan et al. Identification of seven loci affecting mean telomere length and their association with disease. Nature Genetics, v. 45, n. 4, p.422-427, 2013.\n",
        "\n",
        "## Tremor essencial não relacionado a Parkinson:\n",
        "STEFANSSON, Hreinn et al. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nature genetics, v. 41, n. 3, p. 277-279, 2009. \n",
        "\n",
        "SIOKAS, Vasileios et al. Genetic Risk Factors for Essential Tremor: A Review. Tremor and Other Hyperkinetic Movements, v. 10, 2020.\n",
        "\n",
        "## Degeneração macular relacionada à idade:\n",
        "GHEORGHE, Andreea; MAHDI, Labib; MUSAT, Ovidiu. Age-related macular degeneration. Romanian journal of ophthalmology, v. 59, n. 2, p. 74, 2015.  \n",
        "\n",
        "HIRATA, Fabio Endo et al. Association of LOC387715/ARMS2 (rs10490924) gene polymorphism with age-related macular degeneration in the Brazilian population. Ophthalmic genetics, v. 36, n. 3, p. 224-228, 2015.  \n",
        "\n",
        "RIVERA, Andrea et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Human molecular genetics, v. 14, n. 21, p. 3227-3236, 2005.  \n",
        "\n",
        "## Osteoporose (receptor de vitamina D):\n",
        "JIA, Fu et al. Vitamin D receptor Bsm I polymorphism and osteoporosis risk: a meta-analysis from 26 studies. Genetic testing and molecular biomarkers, v. 17, n. 1, p. 30-34, 2013.\n",
        "\n",
        "POURESMAEILI, Farkhondeh et al. Association between vitamin D receptor gene BsmI polymorphism and bone mineral density in a population of 146 Iranian women. Cell Journal (Yakhteh), v. 15, n. 1, p. 75, 2013.\n",
        "\n",
        "MAROZIK, Pavel M. et al. Association of vitamin D receptor gene variation with osteoporosis risk in Belarusian and Lithuanian postmenopausal women. Frontiers in endocrinology, v. 9, p. 305, 2018."
      ],
      "metadata": {
        "id": "QHAHJZ6vWaew"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Referências bibliográficas - CURIOSIDADES"
      ],
      "metadata": {
        "id": "9dAEqH5UV8sh"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Gene guerreiro:\n",
        "STEIN, Dan J. et al. Warriors Versus Worriers: The Role of COMT Gene Variants. Cns Spectrums, v. 11, n. 10, p.745-748, 2006. \n",
        "\n",
        "BRONSON, PO; Merryman, A. “Why Can Some Kids Handle Pressure While Others Fall Apart?” The New York Times Magazine, February 6, 2013.\n",
        "\n",
        "## Habilidade matemática:\n",
        "DOCHERTY, Sophia J. et al. A genome‐wide association study identifies multiple loci associated with mathematics ability and disability. Genes, Brain and Behavior, v. 9, n. 2, p. 234-247, 2010.  \n",
        "\n",
        "SOUZA, Carine Franco de; MATIAS, Neyfsom Carlos Fernandes. Correlatos Cognitivos na Aprendizagem da Matemática: uma revisão da literatura. Bolema: Boletim de Educação Matemática, v. 34, p. 1324-1340, 2020. \n",
        "\n",
        "## Visão:\n",
        "VERHOEVEN, Virginie J. M. et al. Large scale international replication and meta-analysis study confirms association of the 15q14 locus with myopia. The CREAM consortium. Human Genetics, [s.l.], v. 131, n. 9, p.1467-1480, 5 jun. 2012. Springer Nature. http://dx.doi.org/10.1007/s00439-012-1176-0.\n",
        "\n",
        "## Impulsividade:\n",
        "HESS, C., et al. A functional dopamine-β-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. Journal of Neural Transmission, 2009, 116.2: 121-130.   \n",
        "\n",
        "## Preferência por horários diurnos ou noturnos:\n",
        "ZHANG, Luoying; PTÁČEK, Louis J.; FU, Ying-Hui. Diversity of human clock genotypes and consequences. Progress in molecular biology and translational science, v. 119, p. 51-81, 2013.\n",
        "\n",
        "## Predisposição ao alcoolismo:\n",
        "SLOAN, Matthew E. et al. Severity of alcohol dependence is associated with the fatty acid amide hydrolase Pro129Thr missense variant. Addiction Biology, v. 23, n. 1, p.474-484, 2017. \n",
        "\n",
        "IWASAKI, Shinya et al. Association study between alcoholism and endocannabinoid metabolic enzyme genes encoding fatty acid amide hydrolase and monoglyceride lipase in a Japanese population. Psychiatric Genetics, v. 17, n. 4, p.215-220, 2007.\n",
        "\n",
        "## Propensão à dependência de nicotina:\n",
        "BIERUT, Laura Jean et al. Variants in Nicotinic Receptors and Risk for Nicotine Dependence. American Journal Of Psychiatry, [s.l.], v. 165, n. 9, p.1163-1171, set. 2008. American Psychiatric Association Publishing. http://dx.doi.org/10.1176/appi.ajp.2008.07111711. SACCONE, Scott F. et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Human Molecular Genetics, [s.l.], v. 16, n. 1, p.36-49, 29 nov. 2006. Oxford University Press (OUP). http://dx.doi.org/10.1093/hmg/ddl438.\n",
        "\n",
        "## Percepção do gosto amargo:\n",
        "DRAYNA, Dennis. Human taste genetics. Annu. Rev. Genomics Hum. Genet., v. 6, p. 217-235, 2005.   \n",
        "\n",
        "KIM, Un-kyung et al. Positional cloning of the human quantitative trait locus underlying taste sensitivity to phenylthiocarbamide. Science, v. 299, n. 5610, p. 1221-1225, 2003.  \n",
        "\n",
        "TIMPSON, Nic J. et al. TAS2R38 (phenylthiocarbamide) haplotypes, coronary heart disease traits, and eating behavior in the British Women’s Heart and Health Study. The American journal of clinical nutrition, v. 81, n. 5, p. 1005-1011, 2005.  \n",
        "\n",
        "## Cera de ouvido:\n",
        "AARON, Ksenia et al. Ear drops for the removal of ear wax. Cochrane Database of Systematic Reviews, n. 7, 2018.  \n",
        "\n",
        "YOSHIURA, Koh-ichiro et al. A SNP in the ABCC11 gene is the determinant of human earwax type. Nature genetics, v. 38, n. 3, p. 324-330, 2006.  "
      ],
      "metadata": {
        "id": "K6TCYGLhWbsv"
      }
    }
  ],
  "metadata": {
    "colab": {
      "name": "Analisador de DNA X Doenças e Predisposições Genéticas.ipynb",
      "provenance": [],
      "collapsed_sections": [
        "9iaKAOLf26ZW",
        "Pazdmtf_ABMj",
        "0B8WfzZoQTbK",
        "ffiRygfyV4Jj",
        "M75rQSRLV8dB",
        "3zL3gl9YV86I",
        "9dAEqH5UV8sh"
      ],
      "authorship_tag": "ABX9TyNMGqIczmXn4WoubsGNWtR0",
      "include_colab_link": true
    },
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}